Clinical trials
Completed Phase 2 trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,479 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 14 |
| 2001 | 13 |
| 2002 | 29 |
| 2003 | 40 |
| 2004 | 54 |
| 2005 | 52 |
| 2006 | 70 |
| 2007 | 77 |
| 2008 | 78 |
| 2009 | 71 |
| 2010 | 79 |
| 2011 | 106 |
| 2012 | 88 |
| 2013 | 74 |
| 2014 | 72 |
| 2015 | 85 |
| 2016 | 72 |
| 2017 | 85 |
| 2018 | 70 |
| 2019 | 57 |
| 2020 | 50 |
| 2021 | 47 |
| 2022 | 28 |
| 2023 | 19 |
| 2024 | 21 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,479 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 91 |
| GlaxoSmithKline | 83 |
| European Organisation for Research and Treatment of Cancer - EORTC | 56 |
| University Hospital, Ghent | 52 |
| Boehringer Ingelheim | 48 |
| Bayer | 47 |
| Hoffmann-La Roche | 43 |
| Sanofi | 41 |
| Janssen Research & Development, LLC | 39 |
| Bristol-Myers Squibb | 38 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 95 |
| Carcinoma, Non-Small-Cell Lung | 44 |
| Neoplasm Metastasis | 43 |
| Arthritis, Rheumatoid | 39 |
| Colitis, Ulcerative | 39 |
| Neoplasms | 39 |
| Ovarian Neoplasms | 31 |
| Colorectal Neoplasms | 30 |
| Recurrence | 30 |
| Influenza, Human | 29 |
Trials
Showing 1 to 25 of 1,479. Each trial links to its page on Pharma Observatory.
1,379 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.